Ildong Pharmaceutical Co., Ltd. (KRX:249420)
South Korea
· Delayed Price · Currency is KRW 12,700
+50 (0.40%)
At close: Jun 5, 2025, 3:30 PM KST
Ildong Pharmaceutical Revenue
Ildong Pharmaceutical had revenue of 135.98B KRW in the quarter ending March 31, 2025, a decrease of -10.01%. This brings the company's revenue in the last twelve months to 599.82B, down -0.99% year-over-year. In the year 2024, Ildong Pharmaceutical had annual revenue of 614.94B with 2.36% growth.
Revenue (ttm)
599.82B
Revenue Growth
-0.99%
P/S Ratio
0.59
Revenue / Employee
580.66M
Employees
1,033
Market Cap
354.74B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,898.69B |
| Celltrion | 3,662.23B |
| ALTEOGEN | 151.65B |
| Yuhan | 2,114.76B |
| SK Biopharmaceuticals | 578.00B |
| HLB Co., Ltd. | 74.64B |
| PharmaResearch | 392.31B |
| LigaChem Biosciences | 146.42B |